Abstract | BACKGROUND: RESULTS: Twenty-seven patients with newly diagnosed non-Hodgkin lymphoma were recruited retrospectively. [ 68Ga]pentixafor PET showed increased radioactivity in lymphoplasmacytic lymphoma (n = 8), marginal zone lymphoma (n = 4), diffuse large B cell lymphoma (n = 3), follicular lymphoma (n = 2), mantle cell lymphoma (n = 1), unclassified indolent B cell lymphoma (n = 3), and enteropathy associated T cell lymphoma (n = 3). However, peripheral T cell lymphoma, not otherwise specified (n = 1), and NK/ T cell lymphoma (n = 2) were not avid for [ 68Ga]pentixafor. In comparison to [18F]FDG PET, [ 68Ga]pentixafor PET demonstrated more extensive disease and higher radioactivity in lymphoplasmacytic lymphoma and marginal zone lymphoma. CONCLUSION:
|
Authors | Qingqing Pan, Yaping Luo, Yan Zhang, Long Chang, Ji Li, Xinxin Cao, Jian Li, Fang Li |
Journal | EJNMMI research
(EJNMMI Res)
Vol. 10
Issue 1
Pg. 89
(Aug 05 2020)
ISSN: 2191-219X [Print] Germany |
PMID | 32757068
(Publication Type: Journal Article)
|